Comparison of 4 Tactical Tourniquets Used in War Medicine
2 other identifiers
interventional
46
1 country
1
Brief Summary
Bleeding remains the leading cause of death in combat, and the literature suggests that tourniquetable hemorrhage is the second leading cause of preventable death, behind non- tourniquetable hemorrhage. Currently, most Western armed forces recommend the use of the tactical tourniquet in combat for the management of tourniquetable hemorrhage. The SOFTT® tourniquet (Tactical Medical Solutions, Anderson) is the tactical tourniquet currently in use by the French armed forces. As the contract will soon come to an end, the question of its renewal arises. The purpose of this study is to compare 4 commercially available tactical tourniquets in healthy volunteers. The hypothesis of the research is that one of the 4 tourniquets compared is faster to set up than the others.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2021
CompletedFirst Posted
Study publicly available on registry
May 4, 2021
CompletedStudy Start
First participant enrolled
May 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 14, 2021
CompletedJuly 7, 2021
July 1, 2021
17 days
April 29, 2021
July 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time required to apply the tactical tourniquet.
The tourniquet application time, in seconds, measured with a stopwatch. The stopwatch will be started when the fitter takes the tourniquet, pre-positioned in a tourniquet pouch on his bullet vest. The stopwatch will be stopped as soon as at least one of the following conditions is verified * the fitter judges the fitting to be effective * the fitter cannot tighten any more (technical limit) * the tourniquet is too painful for the receiver.
Each day during 4 consecutive days
Secondary Outcomes (5)
Occlusion of the downstream arterial flow following after tactical tourniquet application
Each day during 4 consecutive days
Ease of use of the tactical tourniquet
Each day during 4 consecutive days
Rusticity of the tactical tourniquet
Each day during 4 consecutive days
Stability of the tactical tourniquet
Each day during 4 consecutive days
Pain experienced by the receiver during application of the tactical tourniquet
Each day during 4 consecutive days
Study Arms (4)
SOFTT® Gen 4 tactical tourniquet
ACTIVE COMPARATORThe SOFTT® Gen 4 (Tactical Medical Solutions, Anderson) tactical tourniquet will be assessed.
CAT® Gen 7 tactical tourniquet
ACTIVE COMPARATORThe CAT® Gen 7 (C-A-T® Resources, Rock Hill) tactical tourniquet will be assessed.
SAM XT® tactical tourniquet
ACTIVE COMPARATORThe SAM XT® (SAM Medical Products®, Wilsonville) tactical tourniquet will be assessed.
RMT® 1.5 tactical tourniquet
ACTIVE COMPARATORThe RMT® 1.5 (m2®, Winooski) tactical tourniquet will be assessed.
Interventions
The tactical tourniquet will be set up to the upper limb and the lower limb during a maximum of 2 minutes.
The efficacy of tactical tourniquet set up will be assessed by medical ultrasound.
The participants will have to fill a questionnaire assessing pain (for the "receiver"), ease of use, stability and rusticity (for the "fitter").
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years;
- Student of the Military Health School of Lyon Bron (Ecoles Militaires de Santé de Lyon Bron; EMSLB);
- Periodic medical examination up to date with the mention "fitness for duty";
- Holder of the "Combat Rescue Level 1" training.
You may not qualify if:
- Vascular pathology;
- Current progressive pathology of any kind;
- History of thrombo-embolic disease;
- Presence of cardiovascular risk factors (diabetes, hypertension, dyslipidemia, smoking \> 1 cigarette/day, BMI \> 25);
- Iliofemoral and axillary vascular abnormalities detected by systematic Doppler ultrasound;
- Presence of symptoms suggestive of COVID-19;
- Positive COVID-19 antigen test;
- Pregnant or breastfeeding woman.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital d'Instruction des Armées Desgenettes
Lyon, 69003, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2021
First Posted
May 4, 2021
Study Start
May 28, 2021
Primary Completion
June 14, 2021
Study Completion
June 14, 2021
Last Updated
July 7, 2021
Record last verified: 2021-07